Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference Feb 25, 2026 04:05PM
TD Cowen Names Enliven Therapeutics (ELVN) Best Smidcap Idea Jun 20, 2025 10:31AM
Enliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares Jun 16, 2025 04:05PM
Enliven Therapeutics, Inc (ELVN) Prices 8.39M Share Offering at $19.66/sh Jun 13, 2025 09:31AM
Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Jun 13, 2025 09:30AM


Jun 13, 2025 06:15AM Enliven Therapeutics, Inc (ELVN) Announces Proposed $200M Share Offering
Jun 13, 2025 06:10AM Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
May 22, 2025 04:05PM Enliven Therapeutics to Present at Upcoming Investor Conferences
Feb 25, 2025 04:05PM Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Sep 30, 2024 08:38AM TD Cowen Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Aug 14, 2024 11:08AM TD Cowen Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Feb 27, 2024 04:05PM Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
Feb 23, 2023 05:20PM Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million